Clinical Trial RESULTS
Clinical Trial
RESULTS
Research Sponsor: AstraZeneca AB
Drugs Studied: AZD9567
National Clinical Trial #: NCT02512575
Protocol #: D6470C00001
Study Date: November 2015 to September 2016
Short Study Title: A study in healthy participants to see how AZD9567
acts in the body and how safe it is to take
Thank you!
As a clinical study participant, you belong to a large community of participants around
the world. You help researchers answer important health questions and discover new
medical treatments.
Thank you for taking part in the clinical study for the drug AZD9567. This drug is being
developed to treat inflammatory diseases, or diseases that cause swelling within the
body. One of these diseases is called rheumatoid arthritis, or RA. RA can affect the joints,
causing swelling, pain, and stiffness. You and all of the participants helped researchers
learn how AZD9567 acts in the body and if the drug causes medical problems.
AstraZeneca AB, the sponsor of this study, thanks you for your help and thinks it
is important for you to know the results of your study. An independent non-profit
organization called CISCRP prepared this summary of the study results for you with the
help of a medical writing organization. We hope it helps you understand and feel proud
of your important role in medical research. If you have questions about the results,
please speak with the doctor or staff at your study site.
11